The M. D. Anderson proton therapy system
Authors: Smith Alfred , Gillin Michael , Bues Martin , Zhu X. Ronald , Suzuki Kazumichi , Mohan Radhe , Woo Shiao , Lee Andrew , Komaki Ritsko , Cox James , Hiramoto Kazuo , Akiyama Hiroshi , Ishida Takayuki , Sasaki Toshie , Matsuda Koji 
Published: August 2009

Purpose: The purpose of this study is to describe the University of Texas M. D. Anderson proton therapy system (PTC‐H) including the accelerator, beam transport, and treatment delivery systems, the functionality and clinical parameters for passive scattering and pencil beam scanning treatment modes, and the results of acceptance tests.

Methods: The PTC‐H has a synchrotron and four treatment rooms. An overall control system manages the treatment, physics, and service modes of operation. An independent safety system ensures the safety of patients, staff, and equipment. Three treatment rooms have isocentric gantries and one room has two fixed horizontal beamlines, which include a large‐field treatment nozzle, used primarily for prostate treatments, and a small‐field treatment nozzle for ocular treatments. Two gantry treatment rooms and the fixed‐beam treatment room have passive scattering nozzles. The third gantry has a pencil beam scanning nozzle for the delivery of intensity modulated proton treatments (IMPT) and single field uniform dose (SFUD) treatments. The PTC‐H also has an experimental room with a fixed horizontal beamline and a passive scattering nozzle. The equipment described above was provided by Hitachi, Ltd. Treatment planning is performed using the Eclipse system from Varian Medical Systems and data management is handled by the MOSAIQ system from IMPAC Medical Systems, Inc. The large‐field passive scattering nozzles use double scattering systems in which the first scatterers are physically integrated with the range modulation wheels. The proton beam is gated on the rotating range modulation wheels at gating angles designed to produce spread‐out‐Bragg peaks ranging in size from . Field sizes of up to can be achieved with the double scattering system. The IMPT delivery technique is discrete spot scanning, which has a maximum field size of . Depth scanning is achieved by changing the energy extracted from the synchrotron (energy can be changed pulse to pulse). The PTC‐H is fully integrated with DICOM‐RT ION interfaces for imaging, treatment planning, data management, and treatment control functions.

Results: The proton therapy system passed all acceptance tests for both passive scattering and pencil beam scanning. Treatments with passive scattering began in May 2006 and treatments with the scanning system began in May 2008. The PTC‐H was the first commercial system to demonstrate capabilities for IMPT treatments and the first in the United States to treat using SFUD techniques. The facility has been in clinical operation since May 2006 with up‐time of approximately 98%.

Conclusions: As with most projects for which a considerable amount of new technology is developed and which have duration spanning several years, at project completion it was determined that several upgrades would improve the overall system performance. Some possible upgrades are discussed. Overall, the system has been very robust, accurate, reproducible, and reliable. The authors found the pencil beam scanning system to be particularly satisfactory; prostate treatments can be delivered on the scanning nozzle in less time than is required on the passive scattering nozzle.